Case Study

Delivering 240% of Enrollment Goal With 100% Retention in a CGM Study

Tekton’s Wichita, Kansas site supported a continuous glucose monitoring device trial involving participants with gestational, type 1, and type 2 diabetes. Personalized outreach to a pre-identified patient pool helped the site exceed enrollment expectations while retaining every participant.

  • Delivered 240% of the initial enrollment goal
  • 100% participant retention
  • 2-day regulatory turnaround

Talk to Tekton

senior-research-study-participant

About This Study

CLIENT
Biotech
TRIAL
Continuous glucose monitoring device trial
PARTICIPANT POPULATION
Participants with gestational, type 1, and type 2 diabetes
SITE LOCATION
Wichita, KS

Partner With Tekton

Join leading Sponsors and CROs that trust Tekton's sites to support their most important clinical trials.

Complete the form on this page or email to discuss your protocol, target population, timelines, and site needs.

Submit Your Information